Invesque (IVQ) AI Stock Analysis

• Market Cap: $146.25M
• Dividend Yield: N/A
• Average Volume (3M): 13.81K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.06
• Revenue Growth: -10.95%
• EPS Growth: 64.90%
• Country: CA
• Employees: 1,448
• Sector: Real Estate
• Sector Strength: 76
• Industry: Real Estate - Services
• EPS (TTM): -0.83
• Shares Outstanding: 914,074,400
• 10 Day Avg. Volume: 3,251
• 30 Day Avg. Volume: 13,812
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 3.77
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: 9.36
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Invesque faces significant challenges with weak financial performance and valuation concerns, which weigh heavily on the stock. However, recent corporate actions aimed at reducing debt and optimizing capital are positive and provide a glimmer of hope for future stability and growth. Current technical analysis indicates a neutral stance without strong momentum.

Invesque Business Overview & Revenue Model

Company Description

Invesque Inc. (IVQ) is a real estate investment company focused on the healthcare sector, primarily investing in properties used for senior housing, skilled nursing, and other healthcare-related facilities. The company aims to provide investors with attractive returns by acquiring, owning, and managing a diverse portfolio of healthcare properties across North America.

How the Company Makes Money

Invesque makes money primarily through the acquisition and management of income-generating healthcare properties. The company's revenue streams include rental income from leasing its properties to operators of senior housing and healthcare facilities. Additionally, Invesque benefits from property appreciation and strategic property sales. Key partnerships with experienced healthcare operators enhance the company's ability to maintain high occupancy rates and stable rental income, contributing to its overall financial performance.

Invesque Financial Statement Overview

Summary

Invesque faces challenges with declining revenues and profitability, high leverage, and a weakening equity position. Improvements in debt management and a slight increase in free cash flow are positive, but overall financial health remains fragile.

Income Statement

Invesque's financial performance shows a declining trend in revenue over the past few years, with a notable decrease from 2020 to 2024. The Gross Profit Margin has also been decreasing, indicating potential issues in cost management or pricing strategies. Net Profit Margin remains negative, as the company is struggling with consistent net losses. The absence of EBIT in 2024 and negative EBITDA in 2023 further reflect operational challenges.

Balance Sheet

The company's Debt-to-Equity Ratio is high, indicating significant leverage which poses financial risk, especially in a volatile market. Stockholders' Equity has been decreasing, reflecting a weakening financial position. However, the company has managed to reduce its total liabilities and net debt over the years, which is a positive sign. The Equity Ratio is low, further emphasizing the reliance on debt financing.

Cash Flow

Invesque's cash flow from operations has been positive but insufficient to cover capital expenditures consistently, resulting in low free cash flow. However, there has been a positive trend in Free Cash Flow from 2023 to 2024. The Operating Cash Flow to Net Income Ratio indicates a disparity between reported earnings and actual cash generation, suggesting potential issues in earnings quality.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
162.67M	188.75M	198.03M	210.45M	217.39M
	Gross Profit
59.00M	72.41M	95.59M	90.97M	108.39M
	EBIT
0.00	27.74M	32.43M	34.11M	-14.74M
	EBITDA
24.27M	-18.83M	10.38M	49.13M	-101.52M
	Net Income Common Stockholders
-36.14M	-99.24M	-42.01M	-28.54M	-184.00M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
18.16M	10.74M	27.58M	19.37M	34.13M
	Total Assets
637.22M	828.28M	1.10B	1.30B	1.50B
	Total Debt
394.84M	588.25M	765.46M	893.75M	1.05B
	Net Debt
376.68M	577.50M	737.88M	874.38M	1.02B
	Total Liabilities
518.05M	681.18M	865.69M	1.01B	1.21B
	Stockholders Equity
119.17M	146.59M	231.65M	286.26M	293.33M
Cash Flow		Free Cash Flow
4.40M	217.00K	5.40M	11.11M	13.82M
	Operating Cash Flow
9.27M	6.03M	11.91M	18.68M	25.09M
	Investing Cash Flow
152.21M	132.05M	137.49M	119.19M	2.98M
	Financing Cash Flow
-154.07M	-154.92M	-141.19M	-152.63M	-5.78M

Invesque Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.16
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Positive. The current price of 0.16 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.17, and above the 200-day MA of 0.16, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 49.39 is Neutral, neither overbought nor oversold. The STOCH value of 95.24 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IVQ.

Invesque Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EXE	71 Outperform	C$1.21B	16.24	70.86%	3.32%	12.36%	123.26%
SIA	63 Neutral	C$1.58B	34.15	8.99%	5.45%	13.72%	429.22%
Sector *	60 Neutral	$2.79B	11.37	0.20%	8519.74%	6.07%	-14.95%
IVQ	43 Neutral	$146.25M	―	-26.89%	―	-10.95%	64.90%

Invesque Corporate Events

Invesque Reports Q4 2024 Results, Executes Strategic Asset Sales and Capital Restructuring

Invesque Inc. reported its financial results for the fourth quarter and full year 2024, highlighting significant strategic moves, including the sale of seven seniors housing assets for $65.4 million, which helped reduce debt and maintain liquidity. The company also completed the exchange of its convertible debentures and preferred shares, resulting in a streamlined capital structure with new debentures and a substantial increase in common shares. These actions aim to optimize asset value and return value to shareholders, positioning Invesque for future growth and stability in the healthcare real estate sector.